Long-term results in a cohort of medullary thyroid cancer (MTC) patients (pts) in a phase I study of XL184 (BMS 907351), an oral inhibitor of MET, VEGFR2, and RET Meeting Abstract
| Authors: | Kurzrock, R.; Cohen, E. E.; Sherman, S. I.; Pfister, D. G.; Cohen, R. B.; Ball, D.; Hong, D. S.; Ng, C. S.; Salgia, R.; Ratain, M. J. |
| Abstract Title: | Long-term results in a cohort of medullary thyroid cancer (MTC) patients (pts) in a phase I study of XL184 (BMS 907351), an oral inhibitor of MET, VEGFR2, and RET |
| Meeting Title: | 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 28 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2010 Jun 4-8 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2010-05-20 |
| Start Page: | 421s |
| Language: | English |
| ACCESSION: | WOS:000208852004181 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2010.28.15_suppl.5502 |
| Notes: | Meeting Abstract: 5502 -- S -- Source: Wos |
